A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease

Summary

This is a randomized, double-blind phase I clinical trial to evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of AK152 in Healthy Volunteers and Patients with Alzheimer' s Disease.

Timeline

Start

2025-12

Primary completion

2027-06

Completion

2027-06

Drugs

Indications